The classic transient receptor potential channel (TRPC) is likely to be a Ca 2ϩ -permeable cation channel in mammalian cells. Five different TRPC channels have been isolated. Among them, TRPC5 was initially hypothesized to be a store-operated channel (SOC) 1) ; however, it was then shown to be activated by stimulating G protein-coupled receptors (GPCRs). Therefore, TRPC5 was suggested to be a receptoroperated channel (ROC).
TRPM7
, 9) TRPM8, 10) TRPV5, 11) and TRPC6. 12) In the TRPM4 channel, current was recovered by PIP 2 after an initial decay. 13) Previously, we showed that TRPC5 is likely to be a nonselective cationic currents (NSCC) channel, activated by muscarinic receptor stimulation. 3, 14, 15) In subsequent studies, we showed that TRPC5 has two regulatory NSCC pathways activated by stimulation of muscarinic receptors in native tissues 16, 17) : the DAG-protein kinase C (PKC) negative feedback pathway, [16] [17] [18] and the calmodulin (CaM)-myosin light chain kinase (MLCK) positive feedback pathway. [19] [20] [21] To further confirm the identity of TRPC5 as an NSCC activated by muscarinic receptor stimulation, we investigated the effects of intracellular PIP 2 on TRPC5 channels expressed in human embryonic kidney (HEK) cells. We found that the desensitization of TRPC5 current is associated with both PIP 2 and PKC. 17) We also determined that the actin cytoskeleton is involved in the activation and desensitization of TRPC5 currents. Additionally, in mouse ileal myocytes, PIP 2 is associated with the desensitization of carbachol (CCh)-activated inward currents. These results give further evidence that TRPC5 is a candidate NSCC channel, activated by muscarinic receptor stimulation.
MATERIALS AND METHODS

Cell Culture and Transient Transfection
Human embryonic kidney (HEK)293 cells (ATCC, Manassas, VA, U.S.A.) were maintained according to the recommendations of the supplier. For transient transfection, cells were seeded in 6-well plates. The following day, 1 mg/well pcDNA plasmid vectors containing the cDNA for TRPC5-GFP (given kindly by Dr. Shuji Kaneko) and muscarinic receptor 3 were transfected into cells using the transfection reagent FuGENE 6 (Roche Molecular Biochemicals) according to the manufacturer's protocol. After 24-48 h, cells were trypsinized and used for whole-cell recording.
Dissociation of Single Cells from Mouse Ileum Ileal myocytes were enzymatically isolated from the ileal region of Institute for Cancer Research (ICR) mice. Mice of either sex weighing 20-30 g were anaesthetized with carbon dioxide and sacrificed by cervical dislocation. The ileal part of the intestine was cut out. The mucous layer was dissected from the smooth muscle layer with fine scissors and cut into small segments (ca. 2-3 mm). Segments were then digested for 25-30 min at 37°C in Ca 2ϩ -free Tyrode solution containing 0.1% collagenase (Worthington type 2), 0.1% dithiothreitol, 0.1% trypsin inhibitor, and 0.2% bovine serum albumin. Single myocytes were dispersed by gentle agitation of the digested segments with a wide-bored glass pipette and kept at 4°C until use. All experiments were carried out at room temperature within 10 h of harvesting cells. -permeable cation channel in mammalian cells. TRPC5 is desensitized rapidly after activation by G protein-coupled receptor. Here we investigate the mechanisms of desensitization of TRPC5 using patch-clamp recording. TRPC5 was initially activated by muscarinic stimulation using 50 m mM carbachol (CCh) and decayed rapidly in the presence of CCh (desensitization). Intracellularly-applied phosphatidylinositol 4,5-bisphosphate (PIP 2 ) slowed the rate of desensitization. In contrast, several other phosphoinositides, including PI(3,4)P 2 , PI(3,5)P 2 , PI(3,4,5)P 3 and PI(4)P, had no effect on the desensitization of the TRPC5 current. This indicates that PIP 2 attenuates the desensitization of the TRPC5 current in a highly selective manner. Neither wortmannin, an inhibitor of phosphatidylinositol 4-kinase, or poly-L-lysine (PLL), a scavenger of PIP 2 , had any effect on desensitization of the TRPC5 current. PIP 2 breakdown appears to be a required step in the desensitization of TRPC5 current, but PIP 2 depletion alone was insufficient for channel desensitization. TRPC5 was inhibited by cytochalasin D treatment. In mouse ileal myocytes, the desensiWhole-Cell Patch-Clamp Recording Isolated cells were transferred to a small chamber on the stage of an inverted microscope (IX70, Olympus, Japan). Cells were continually perfused with normal Tyrode solution (2-3 ml/min). A glass microelectrode with a resistance of 3-5 MW was used to make a gigaohm seal. The conventional whole-cell patch-clamp technique was adapted to hold the membrane potential at Ϫ60 mV using an Axopatch 200B patch-clamp amplifier (Axon Instrument, U.S.A.). For data acquisition and the application of command pulses, pCLAMP software (v.9.2) and Digidata 1200 (Axon Instruments) were used. Data were analyzed at 5 kHz and displayed on a computer monitor; they were analyzed using pCLAMP and Origin software (Microcal origin v.7.0, U.S.A.).
Involvement of
Solutions and Drugs Tyrode solution contained 135 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, and 10 mM HEPES (N-[2-hydroxyethyl]piperazine-NЈ-[2-ethanesulphonic acid]). The pH was adjusted to 7.4 using NaOH. Cs-rich external solution was made by replacing NaCl and KCl with equimolar CsCl. The pipette solution contained 140 mM CsCl, 10 mM HEPES, 0.2 mM Tris-GTP (Tris-guanosine 5Ј-triphospate), 0.5 mM ethylene glycol-bis-(2-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), and 3 mM Mg-ATP (Mg-adenosine 5Ј-triphosphate). The pH was adjusted to 7.3 with CsOH. Stock solutions of the DMSOsoluble drugs cytochalasin D (5 mM) and wortmannin (100 mM) were made. DiC8-phosphoinositides (Echelon Research Laboratories, Salt Lake City, UT, U.S.A.) were dissolved in deionised and deoxygenated water (0.5 mM) or directly in the pipette solution (if applied at concentrations higher than 20 mM) by a 30-min sonication. All other drugs were obtained from Sigma (U.S.A.).
Statistics All data are expressed as meansϮS.E.M. Statistical significance was determined using Student's unpaired t-tests. p values Ͻ0.05 were considered statistically significant. The number of cell recordings in each experiment is represented by n. ] i as a control to determine the I-V relationship of TRPC5 activated by CCh. To examine I-V relationships, we applied a ramp pulse from ϩ100 mV to Ϫ100 mV for 500 ms. When 50 mM CCh was added at a holding potential of Ϫ60 mV, an inward current was activated in HEK293 cell expressing TRPC5 (Fig.  1Aa) . The I-V relationship, obtained by subtracting the current observed in the absence of CCh from the current obtained in its presence, showed a typical doubly rectifying shape (Fig. 1Ab ). TRPC5 currents were not activated by CCh in mock transfected cells (Fig. 1B) . We used only results obtained from cells producing the typical I-V relationship of TRPC5. The TRPC5 current that was activated by stimulating muscarinic receptors decayed spontaneously to basal levels, even during CCh application (Fig. 1Aa) . This process is referred to as desensitization. Previous studies assumed that the depletion of PIP 2 by the hydrolysis of PIP 2 through PLCb induces the activation of TRPC5. We first examined the role of the PLC substrate, PIP 2 , on the TRPC5 current. To study the effects of PIP 2 on the agonist-induced TRPC5 current, we included 20 mM dioctanoyl analog of PIP 2 (diC8-PIP 2 ), a more water-soluble short form of PIP 2 , in the recording pipettes. Under these conditions, CCh induced TRPC5 cur- rents, contrary to what was expected. However, the desensitization of the TRPC5 current slowed in response to CCh (Fig.  1Ca) . During desensitization, the I-V relationship showed a typical doubly rectifying shape (Fig. 1Cb) . In TRPC5-expressing cells, the inward current spontaneously declined to 1.6Ϯ3.0% of the initial peak amplitude found 2 min after CCh application (nϭ20). In TRPC5-expressing cells included PIP 2 in recording pipettes, however, the inward current remained at 57Ϯ10% of the initial peak amplitude 2 min after CCh application. There was no significant change in the activation process (nϭ10) (Fig. 1D ). The decay rates were significantly different. Montell and colleagues 12) have recently demonstrated the direct binding of several phosphoinositides (PIs) to other members of the TRP superfamily, including TRPC1, 5, 6 and 7. Therefore, we examined the effects of other phosphoinositides (PIs) on TRPC5 currents. We investigated the effect of PI(3,4,5)P 3 , PI(3,4)P 2 , PI(3,5)P 2 , and PI(4)P. Taking into account differences in the binding affinities, 12) PIs were applied (similarly to PIP 2 ) at the following concentrations: PI(3,4,5)P 3 (nϭ7) at 20 mM, PI(3,4)P 2 (nϭ3) and PI(3,5)P 2 (nϭ4) at 100 mM, and PI(4)P (nϭ3) at 200 mM. No attenuation of desensitization was seen (Fig. 2) , highlighting the specificity of the attenuation of PIP 2 on the desensitization of the TRPC5 current. This result is not simply a negative charge effect of PIP 2 .
RESULTS
Effects of PIP
PIP 2 Depletion Is Not Sufficient for Full TRPC5 Desensitization Wortmannin, an inhibitor of phosphatidylinositol 4-kinase, retards the replenishment of PIP 2 , which leads to depletion of the intracellular PIP 2 pool. 22) In the whole-cell mode, 50 mM wortmannin in the pipette solution had no effect on desensitization of the TRPC5 current (Fig. 3Aa) or on the typical doubly rectifying I-V shape (Fig. 3Ab) . Poly-L-lysine (PLL) is a positively charged macromolecule that acts as a scavenger of PIP 2 23,24) and inhibits the activity of the PIP 2 -activated TRPM4 and TRPM8 channels. 13, 25) However, 3 mg/ml PLL in the pipette solution did not cause any significant change in desensitization of the TRPC5 current (Fig. 3Ba) or the typical doubly rectifying I-V shape (Fig. 3Bb) . In TRPC5-expressing cells, the desensitization of the TRPC5 current, by the addition of wortmannin and PLL to the recording pipettes, had no significant effects (nϭ5) (Fig. 3C) . Zhu et al. 17) reported that EGTA, depletion of Mg-ATP, or PKC inhibitor slows the desensitization. Therefore, we examined the effect of wortmannin and PLL on desensitization of the TRPC5 current in the presence of EGTA or PKC inhibitor. In this paper, we performed all experiments with internal solution containing 0.5 mM EGTA. In an internal solution containing 2 mM EGTA, the desensitization of TRPC5 current was attenuated. 17 ) When we applied wortmannin or PLL in 2 mM EGTA pipette solution, there was no effect of wortmannin or PLL on desensitization of TRPC5 current (Fig. 4A) . PKC inhibitor slowed the desensitization of TRPC5 current. 17 ) When we applied wortmannin or PLL in pipette solution and PKC inhibitor in bath solution, there was no effect of wortmannin or PLL on desensitization of TRPC5 current (Fig. 4B ). These data demonstrate that PIP 2 blockade of the TRPC5 current desensitization is necessary but not sufficient for the full desensitization of the TRPC5 current.
The Role of the Actin Cytoskeleton on TRPC5 Current PIP 2 interacts with cytoskeletal proteins and anchors various signalling molecules to the plasma membrane. 26, 27) Proteins involved in cytoskeletal remodeling are important targets of PIP 2 signalling. Therefore, we investigated whether the association of PIP 2 with the actin cytoskeleton has a role in PIP 2 regulation of desensitization of the TRPC5 current. TRPC5-expressing cells were treated with 0.5 mM cytochalasin D, a potent cell permeable fungal toxin, which inhibits actin polymerization and thus disrupts actin microfilaments. Cytochalasin D completely inhibited the activation of the TRPC5 current (Fig. 4) , such that it was impossible to investigate whether the association of PIP 2 with the actin cytoskeleton has a role in regulating desensitization of this current And cytochalasin D also inhibited the desensitization of TRPC5 current when it was added after the activation of TRPC5 current (Fig. 5B) . These results suggest that the cytoskeleton is involved in both activation and desensitization of TRPC5 current.
PIP 2 Attenuates Desensitization of the CCh-Activated Current (I CCh ) in Mouse Ileal Myocyte Since I CCh appears to be largely mediated by TRPC5, 3, 21) it was important to determine whether desensitization of I CCh depends on PIP 2 . CsCl-rich solutions were used in both the pipette and bath to record I CCh . Under a voltage clamp, at a holding potential of Ϫ60 mV, 50 mM CCh induced I CCh . Spontaneous decay of I CCh (desensitization of I CCh ) occurred (nϭ5, Fig. 5Aa ). To determine the I-V relationship, we applied a ramp pulse from ϩ100 to Ϫ100 mV for 500 ms. The I-V relationship showed a typical doubly rectifying shape (Fig. 5Ab) . In the presence of 20 mM diC8-PIP 2 in the pipette solution, the desensitization of I CCh slowed (Fig. 5Ba) . During desensitization, the I-V relationship showed a typical doubly rectifying shape (Fig. 5Bb) . In control mouse ileal myocytes, the inward current spontaneously declined to 7.1Ϯ3.1% of the initial peak amplitude after 2 min of CCh application (nϭ5). In the presence of 20 mM diC8-PIP 2 in the pipette solution, however, the inward current remained at 64Ϯ5.1% of the initial peak amplitude 2 min after CCh application. There was no change in the activation process (nϭ5) (Fig. 5C ). These results suggest that TRPC5 is a candidate NSCC, activated by muscarinic receptor stimulation in gastrointestinal smooth muscle cells. 
DISCUSSION
We have demonstrated that intracellularly-applied PIP 2 attenuated the desensitization of TRPC5 currents. We have also shown that the actin cytoskeleton plays a role in the activation and the desensitization of these currents. Moreover, we have shown that in mouse ileal myocytes, the desensitization of I CCh also slowed when PIP 2 was included in the recording pipettes. These results suggest that PIP 2 is involved in the desensitization of TRPC5 currents and that TRPC5 is still a candidate NSCC channel, activated by muscarinic receptor stimulation.
Among the isolated TRP channels, TRPC4 and TRPC5 are in the same group. Recently, Otsuguro et al. 28) suggested that TRPC4a, but not TRPC4b, was strongly inhibited by intracellularly applied PIP 2 , and that its inhibitory action was dependent on the association of TRPC4a with actin cytoskeleton. Its inhibitory action was prevented by the application of cytochalasin D or the deletion of the C-terminal PDZ binding motif (Thr-Thr-Arg-Leu), which links TRPC4 to F-actin through NHERF and ezrin. 28) The activation kinetics of rat TRPC5 was modulated by the scaffolding protein ezrin/ radixin/moesin-binding phosphoprotein-50 (EBP50). 29 ) PIP 2 did not inhibit TRPC5 current although TRPC5 was most similar at the amino acid sequence to TRPC4a (Fig. 1C) . On the contrary, PIP 2 slowed the desensitization process of TRPC5. In our previous study, we showed the desensitization depended upon PKC phosphorylation of TRPC5 channel. 17) PIP 2 scavenger, PLL or wortmannin, did not reverse the inhibition of the desensitization of TRPC5 by PKC inhibitor (Fig. 4B) . We suggest that PKC might be the downstream target of PIP 2 rather than acting independently of PIP 2 . In TRPC5, cytochalasin D inhibited the activation and the desensitization of these current (Fig. 5) . We already showed that MLCK is involved in the activation process of TRPC5 channel, 20) while other research showed that actin is linked with TRPC4 and TRPC5 through NHERF and ezrin. The effect of cytochalasin D on both activation and desensitization suggest that TRPC5 channel exists as a multi-proteins complex and actin has important roles for activation and desensitization of TRPC5 channel.
In our examination of TRPC5, however, intracellularly applied PIP 2 attenuated the desensitization of TRPC5 currents. Additionally, we showed that the actin cytoskeleton had a role in activation and desensitization of these currents. In our previous study, the deletion of the C-terminal PDZ binding motif (Thr-Thr-Arg-Leu) inhibited the activation of TRPC4 and TRPC5 channels expressed in HEK cells 17) and slowed the activation of rat TRPC5. 29) We determined that attenuation of the desensitization of TRPC5 current was specific to PIP 2 , as other PIs had no effect. This indicates that the effects are not simply a negative charge effect, as in the case of activation of the TRPC4 current. 28) Lee et al. 3) suggested that TRPC5 was a promising candidate for muscarinic cationic channel in murine gastric myocytes. As the properties of I CCh in murine ileal myocytes are consistent with a previous report about nonselective cation channels activated by muscarinic stimulation in murine gastric myocytes, 30) TRPC5 may also be a promising candidate for muscarinic cationic channel in murine ileal myocytes. The effect of CaM and MLCK on murine ileal myocytes was similar to that of TRPC5, suggesting TRPC5 to be a candidate for NSCC, activated by muscarinic stimulation. 20, 21) In the present study, the desensitization of I CCh in mouse ileal myocytes also slowed when PIP 2 was included in recording pipettes.
In conclusion, PIP 2 is involved in the desensitization of TRPC5 currents. TRPC5 remains a candidate for NSCC channel which is activated by muscarinic receptor stimulation. 
